Phase I study of nedaplatin and S-1 in patients with advanced or relapsed squamous cell lung cancer
Not Applicable
- Conditions
- Squamous cell lung cancer
- Registration Number
- JPRN-UMIN000036387
- Lead Sponsor
- Kagawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
1)Severe complication 2)interstitial penumonia 3)positive for HBs antigen 4)Pleural effusion, ascites, or pericardial effusion which need drainage 5)double malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method determination of maximum dose and estimation of recommendation dose
- Secondary Outcome Measures
Name Time Method